Yver Antoine

EVP &Chairman Of Development | Chief Medical Officer

1 company

Average

Trades Analyzed

12M Win Rate

11.8%

Avg 3M Return

-4.0%

Avg 12M Return

-59.0%

Yver Antoine is an EVP &Chairman Of Development at Centessa Pharmaceuticals plc. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $31.0M based on current market prices.

Holdings by Company

CNTAJun 1, 2023

Current Shares783.1K

Value$30.99M

Net Activity-219,908

Bought: 0Sold: 219.9K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 1, 2023	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	6,500	$4.45	$28,949.05	-0.8%	+52.1%	+85.2%
May 1, 2023	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	6,800	$4.42	$30,083.20	-0.9%	+68.8%	+95.7%
Apr 3, 2023	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	6,700	$3.69	$24,729.70	-0.8%	+60.5%	+200.5%
Mar 1, 2023	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	7,000	$3.42	$23,970.10	-0.9%	+30.6%	+200.3%
Feb 1, 2023	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	7,700	$3.79	$29,200.71	-0.9%	+18.4%	+108.1%
Jan 4, 2023	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	6,970	$3.18	$22,136.02	-0.9%	+15.2%	+122.3%
Dec 1, 2022	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	9,400	$3.91	$36,743.66	-1.2%	-12.7%	+67.1%
Nov 1, 2022	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	9,700	$4.03	$39,055.11	-1.3%	-8.4%	+64.7%
Oct 3, 2022	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	14,992	$3.94	$59,091.09	-1.0%	-22.9%	+36.0%
Sep 1, 2022	CNTA Centessa Pharmaceuticals Plc	EVP &Chairman Of Development	Sell	10,423	$4.41	$45,987.32	-1.3%	-11.9%	+69.2%